NBC Securities’s Vertex Pharmaceuticals VRTX Stock Holding History

NBC Securities’s Portfolio VRTX Stock Details VRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$110K	Buy	247 +1	+0.4%	+$466	0.01%	1056
2025 Q4	$112K	Buy	246 +58	+31%	+$25K	0.01%	1043
2025 Q3	$73.6K	Sell	188 -172	-48%	-$71.9K	0.01%	1176
2025 Q2	$160K	Buy	360 +15	+4%	+$6.91K	0.01%	906
2025 Q1	$167K	Buy	+345	New	+$161K	0.01%	843
2024 Q4	–	Sell	-160	Closed	-$74K	–	2065
2024 Q3	$74K	Buy	160 +41	+34%	+$19.7K	0.01%	1071
2024 Q2	$55K	Hold	119	–	–	0.01%	1111
2024 Q1	$49K	Buy	119 +19	+19%	+$8.03K	﹤0.01%	1143
2023 Q4	$40K	Buy	100 +1	+1%	+$369	﹤0.01%	1201
2023 Q3	$34K	Buy	+99	New	+$34.6K	﹤0.01%	1256

Other funds holding VRTX

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

NBC Securities's VRTX Position: Q1 2026 in Review

NBC Securities increased its Vertex Pharmaceuticals (VRTX) stake by 0.41% in Q1 2026, buying an estimated $466 and bringing the position to 247 shares worth $110K. The position accounts for 0.01% of the portfolio, ranked #1056.

NBC Securities first reported a position in VRTX in Q3 2023 and has held it in 10 quarters since. The position peaked at $167K in Q1 2025. 1,687 funds tracked by Wall St. Rank hold VRTX as of Q1 2026.

NBC Securities held 247 shares of Vertex Pharmaceuticals worth $110K as of Q1 2026.
NBC Securities bought 1 Vertex Pharmaceuticals share in Q1 2026, an estimated $466.
Vertex Pharmaceuticals made up 0.01% of NBC Securities's portfolio in Q1 2026, its #1056 holding.
NBC Securities first reported a position in Vertex Pharmaceuticals in Q3 2023 and has held it in 10 quarters since.
NBC Securities's Vertex Pharmaceuticals position peaked at $167K in Q1 2025.
1,687 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q1 2026.

Based on NBC Securities's 13F filing for Q1 2026, filed 14 Apr 2026.